This work is licensed under the Creative Commons Attribution 4.0 International License.
Baumgartner RN. Body composition in healthy aging. Ann N Y Acad Sci 2000; 904: 437–48. doi: 10.1111/j.1749-6632.2000.tb06498.xBaumgartnerRNBody composition in healthy aging20009044374810.1111/j.1749-6632.2000.tb06498.xOpen DOISearch in Google Scholar
Barazzoni R, Bischoff SC, Boirie Y, Busetto L, Cederholm T, Dicker D, et al. Sarcopenic obesity: Time to meet the challenge. Clin Nutr 2018; 37(6 Pt A): 1787–93. doi: 10.1016/j.clnu.2018.04.018BarazzoniRBischoffSCBoirieYBusettoLCederholmTDickerDSarcopenic obesity: Time to meet the challenge2018376 Pt A17879310.1016/j.clnu.2018.04.018Open DOISearch in Google Scholar
Gao Q, Mei F, Shang Y, Hu K, Chen F, Zhao L, et al. Global prevalence of sarcopenic obesity in older adults: a systematic review and meta-analysis. Clin Nutr 2021; 40: 4633–41. doi: 10.1016/j.clnu.2021.06.009GaoQMeiFShangYHuKChenFZhaoLGlobal prevalence of sarcopenic obesity in older adults: a systematic review and meta-analysis20214046334110.1016/j.clnu.2021.06.009Open DOISearch in Google Scholar
Gao Q, Hu K, Gao J, Shang Y, Mei F, Zhao L, et al. Prevalence and prognostic value of sarcopenic obesity in patients with cancer: a systematic review and meta-analysis. Nutrition 2022; 101: 111704. doi: 10.1016/j.nut.2022.111704GaoQHuKGaoJShangYMeiFZhaoLPrevalence and prognostic value of sarcopenic obesity in patients with cancer: a systematic review and meta-analysis202210111170410.1016/j.nut.2022.111704Open DOISearch in Google Scholar
Gortan Cappellari G, Brasacchio C, Laudisio D, Lubrano C, Pivari F, Barrea L, et al. Sarcopenic obesity: what about in the cancer setting? Nutrition 2022; 98: 111624. doi: 10.1016/j.nut.2022.111624Gortan CappellariGBrasacchioCLaudisioDLubranoCPivariFBarreaLSarcopenic obesity: what about in the cancer setting?20229811162410.1016/j.nut.2022.111624Open DOISearch in Google Scholar
Carneiro IP, Mazurak VC, Prado CM. Clinical implications of sarcopenic obesity in cancer. Curr Oncol Rep 2016; 18: 62. doi: 10.1007/s11912-016-0546-5CarneiroIPMazurakVCPradoCMClinical implications of sarcopenic obesity in cancer2016186210.1007/s11912-016-0546-5Open DOISearch in Google Scholar
Atkins JL, Wannamathee SG. Sarcopenic obesity in ageing: cardiovascular outcomes and mortality. Br J Nutr 2020; 124: 1102–13. doi: 10.1017/S0007114520002172AtkinsJLWannamatheeSGSarcopenic obesity in ageing: cardiovascular outcomes and mortality202012411021310.1017/S0007114520002172Open DOISearch in Google Scholar
Silveira EA, da Silva Filho RR, Spexoto MCB, Haghighatdoost F, Sarrafzadegan N, de Oliveira C. The role of sarcopenic obesity in cancer and cardiovascular disease: a synthesis of the evidence on pathophysiological aspects and clinical implications. Int J Mol Sci 2021; 22: 4339. doi: 10.3390/ijms22094339SilveiraEAda Silva FilhoRRSpexotoMCBHaghighatdoostFSarrafzadeganNde OliveiraCThe role of sarcopenic obesity in cancer and cardiovascular disease: a synthesis of the evidence on pathophysiological aspects and clinical implications202122433910.3390/ijms22094339Open DOISearch in Google Scholar
Donini LM, Busetto L, Bischoff SC, Cederholm T, Ballesteros-Pomar MD, Batsis JA, et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Obes Facts 2022; 15: 321–35. doi: 10.1159/000521241DoniniLMBusettoLBischoffSCCederholmTBallesteros-PomarMDBatsisJADefinition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement2022153213510.1159/000521241Open DOISearch in Google Scholar
Batsis JA, Villareal DT. Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies. Nat Rev Endocrinol 2018; 14: 513–37. doi: 10.1038/s41574-018-0062-9BatsisJAVillarealDTSarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies2018145133710.1038/s41574-018-0062-9Open DOISearch in Google Scholar
Chargi N, Bril SI, Swartz JE, Wegner I, Willems SM, de Bree R. Skeletal muscle mass is an imaging biomarker for decreased survival in patients with oropharyngeal squamous cell carcinoma. Oral Oncol 2020; 101: 104519. doi: 10.1016/j.oraloncology.2019.104519ChargiNBrilSISwartzJEWegnerIWillemsSMde BreeRSkeletal muscle mass is an imaging biomarker for decreased survival in patients with oropharyngeal squamous cell carcinoma202010110451910.1016/j.oraloncology.2019.104519Open DOISearch in Google Scholar
Kiss N, Beraldo J, Everitt S. Early skeletal muscle loss in non-small cell lung cancer patients receiving chemoradiation and relationship to survival. Support Care Cancer 2019; 27: 2657–64. doi: 10.1007/s00520-018-4563-9KissNBeraldoJEverittSEarly skeletal muscle loss in non-small cell lung cancer patients receiving chemoradiation and relationship to survival20192726576410.1007/s00520-018-4563-9Open DOISearch in Google Scholar
Recio-Boiles A, Galeas JN, Goldwasser B, Sanchez K, Man LMW, Gentzler RD, et al. Enhancing evaluation of sarcopenia in patients with non-small cell lung cancer (NSCLC) by assessing skeletal muscle index (SMI) at the first lumbar (L1) level on routine chest computed tomography (CT). Support Care Cancer 2018; 26: 2353–59. doi: 10.1007/s00520-018-4051-2Recio-BoilesAGaleasJNGoldwasserBSanchezKManLMWGentzlerRDEnhancing evaluation of sarcopenia in patients with non-small cell lung cancer (NSCLC) by assessing skeletal muscle index (SMI) at the first lumbar (L1) level on routine chest computed tomography (CT)20182623535910.1007/s00520-018-4051-2Open DOISearch in Google Scholar
Lodewick TM, van Nijnatten TJ, van Dam RM, van Mierlo K, Dello SA, Neumann UP, et al. Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases? HPB (Oxford) 2015; 17: 438–46. doi: 10.1111/hpb.12373LodewickTMvan NijnattenTJvan DamRMvan MierloKDelloSANeumannUPAre sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases?2015174384610.1111/hpb.12373Open DOISearch in Google Scholar
Grotenhuis BA, Shapiro J, van Adrichem S, de Vries M, Koek M, Wijnhoven BP, et al. Sarcopenia/muscle mass is not a prognostic factor for short- and long-term outcome after esophagectomy for cancer. World J Surg 2016; 40: 2698–704. doi: 10.1007/s00268-016-3603-1GrotenhuisBAShapiroJvan AdrichemSde VriesMKoekMWijnhovenBPSarcopenia/muscle mass is not a prognostic factor for short- and long-term outcome after esophagectomy for cancer201640269870410.1007/s00268-016-3603-1Open DOISearch in Google Scholar
Kim YM, Kim JH, Baik SJ, Chun J, Youn YH, Park H. Sarcopenia and sarcopenic obesity as novel risk factors for gastric carcinogenesis: a health checkup cohort study. Front Oncol 2019; 9: 1249. doi: 10.3389/fonc.2019.01249KimYMKimJHBaikSJChunJYounYHParkHSarcopenia and sarcopenic obesity as novel risk factors for gastric carcinogenesis: a health checkup cohort study20199124910.3389/fonc.2019.01249Open DOISearch in Google Scholar
Lou N, Chi CH, Chen XD, Zhou CJ, Wang SL, Zhuang CL, et al. Sarcopenia in overweight and obese patients is a predictive factor for postoperative complication in gastric cancer: a prospective study. Eur J Surg Oncol 2017; 43: 188–95. doi: 10.1016/j.ejso.2016.09.006LouNChiCHChenXDZhouCJWangSLZhuangCLSarcopenia in overweight and obese patients is a predictive factor for postoperative complication in gastric cancer: a prospective study2017431889510.1016/j.ejso.2016.09.006Open DOISearch in Google Scholar
Nishigori T, Tsunoda S, Okabe H, Tanaka E, Hisamori S, Hosogi H, et al. Impact of sarcopenic obesity on surgical site infection after laparoscopic total gastrectomy. Ann Surg Oncol 2016; 23(Suppl 4): 524–31. doi: 10.1245/s10434-016-5385-yNishigoriTTsunodaSOkabeHTanakaEHisamoriSHosogiHImpact of sarcopenic obesity on surgical site infection after laparoscopic total gastrectomy201623Suppl 45243110.1245/s10434-016-5385-yOpen DOISearch in Google Scholar
Palmela C, Velho S, Agostinho L, Branco F, Santos M, Santos MP, et al. Body composition as a prognostic factor of neoadjuvant chemotherapy toxicity and outcome in patients with locally advanced gastric cancer. J Gastric Cancer 2017; 17: 74–87. doi: 10.5230/jgc.2017.17.e8PalmelaCVelhoSAgostinhoLBrancoFSantosMSantosMPBody composition as a prognostic factor of neoadjuvant chemotherapy toxicity and outcome in patients with locally advanced gastric cancer201717748710.5230/jgc.2017.17.e8Open DOISearch in Google Scholar
Sugawara K, Yamashita H, Okumura Y, Yagi K, Yoshimura S, Kawasaki K, et al. Relationships among body composition, muscle strength, and sarcopenia in esophageal squamous cell carcinoma patients. Support Care Cancer 2020; 28: 2797–803. doi: 10.1007/s00520-019-05110-7SugawaraKYamashitaHOkumuraYYagiKYoshimuraSKawasakiKRelationships among body composition, muscle strength, and sarcopenia in esophageal squamous cell carcinoma patients202028279780310.1007/s00520-019-05110-7Open DOISearch in Google Scholar
Zhang WT, Lin J, Chen WS, Huang YS, Wu RS, Chen XD, et al. Sarcopenic obesity is associated with severe postoperative complications in gastric cancer patients undergoing gastrectomy: a prospective study. J Gastrointest Surg 2018; 22: 1861–69. doi: 10.1007/s11605-018-3835-5ZhangWTLinJChenWSHuangYSWuRSChenXDSarcopenic obesity is associated with severe postoperative complications in gastric cancer patients undergoing gastrectomy: a prospective study20182218616910.1007/s11605-018-3835-5Open DOISearch in Google Scholar
Giani A, Famularo S, Riva L, Tamini N, Ippolito D, Nespoli L, et al. Association between specific presurgical anthropometric indexes and morbidity in patients undergoing rectal cancer resection. Nutrition. 2020; 75–76: 110779. doi: 10.1016/j.nut.2020.110779GianiAFamularoSRivaLTaminiNIppolitoDNespoliLAssociation between specific presurgical anthropometric indexes and morbidity in patients undergoing rectal cancer resection202075–7611077910.1016/j.nut.2020.110779Open DOISearch in Google Scholar
Han JS, Ryu H, Park IJ, Kim KW, Shin Y, Kim SO, et al. Association of body composition with long-term survival in non-metastatic rectal cancer patients. Cancer Res Treat 2020; 52: 563–72. doi: 10.4143/crt.2019.249HanJSRyuHParkIJKimKWShinYKimSOAssociation of body composition with long-term survival in non-metastatic rectal cancer patients2020525637210.4143/crt.2019.249Open DOISearch in Google Scholar
Malietzis G, Currie AC, Athanasiou T, Johns N, Anyamene N, Glynne-Jones R, et al. Influence of body composition profile on outcomes following colorectal cancer surgery. Br J Surg 2016; 103: 572–80. doi: 10.1002/bjs.10075MalietzisGCurrieACAthanasiouTJohnsNAnyameneNGlynne-JonesRInfluence of body composition profile on outcomes following colorectal cancer surgery20161035728010.1002/bjs.10075Open DOISearch in Google Scholar
Gruber ES, Jomrich G, Tamandl D, Gnant M, Schindl M, Sahora K. Correction: Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resecTable pancreatic ductal adenocarcinoma. PLoS One 2020; 15: e0244896. doi: 10.1371/journal.pone.0244896. Erratum for: PLoS One 2019 6; 14: e0215915. doi: 10.1371/journal.pone.0215915GruberESJomrichGTamandlDGnantMSchindlMSahoraKCorrection: Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resecTable pancreatic ductal adenocarcinoma202015e024489610.1371/journal.pone.0244896Erratum for: PLoS One 2019 6; 14: e0215915.10.1371/journal.pone.0215915Open DOISearch in Google Scholar
Kobayashi A, Kaido T, Hamaguchi Y, Okumura S, Shirai H, Yao S, et al. Impact of sarcopenic obesity on outcomes in patients undergoing hepatectomy for hepatocellular carcinoma. Ann Surg 2019; 269: 924–31. doi: 10.1097/SLA.0000000000002555KobayashiAKaidoTHamaguchiYOkumuraSShiraiHYaoSImpact of sarcopenic obesity on outcomes in patients undergoing hepatectomy for hepatocellular carcinoma20192699243110.1097/SLA.0000000000002555Open DOISearch in Google Scholar
Kimura Y, Yamada M, Ohji S, Ishiyama D, Nishio N, Otobe Y, et al. Presence of sarcopenic obesity and evaluation of the associated muscle quality in Japanese older men with prostate cancer undergoing androgen deprivation therapy. J Geriatr Oncol 2019; 10: 835–8. doi: 10.1016/j.jgo.2019.03.017KimuraYYamadaMOhjiSIshiyamaDNishioNOtobeYPresence of sarcopenic obesity and evaluation of the associated muscle quality in Japanese older men with prostate cancer undergoing androgen deprivation therapy201910835810.1016/j.jgo.2019.03.017Open DOISearch in Google Scholar
Kocher NJ, Jafri S, Balabhadra S, Lehman E, Gardner J, Vijay K, et al. Is sarcopenia and sarcopenic obesity associated with clinical and pathological outcomes in patients undergoing radical nephroureterectomy? Urol Oncol 2018; 36: 156.e17–156.e22. doi: 10.1016/j.urolonc.2017.12.004KocherNJJafriSBalabhadraSLehmanEGardnerJVijayKIs sarcopenia and sarcopenic obesity associated with clinical and pathological outcomes in patients undergoing radical nephroureterectomy?201836156.e17156.e2210.1016/j.urolonc.2017.12.004Open DOISearch in Google Scholar
Cushen SJ, Power DG, Murphy KP, McDermott R, Griffin BT, Lim M, et al. Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel. Clin Nutr ESPEN 2016; 13: e39–45. doi: 10.1016/j.clnesp.2016.04.001CushenSJPowerDGMurphyKPMcDermottRGriffinBTLimMImpact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel201613e394510.1016/j.clnesp.2016.04.001Open DOISearch in Google Scholar
Rier HN, Jager A, Sleijfer S, van Rosmalen J, Kock MCJM, Levin MD. Low muscle attenuation is a prognostic factor for survival in metastatic breast cancer patients treated with first line palliative chemotherapy. Breast 2017; 31: c9–15. doi: 10.1016/j.breast.2016.10.014RierHNJagerASleijferSvan RosmalenJKockMCJMLevinMDLow muscle attenuation is a prognostic factor for survival in metastatic breast cancer patients treated with first line palliative chemotherapy201731c91510.1016/j.breast.2016.10.014Open DOISearch in Google Scholar
Heidelberger V, Goldwasser F, Kramkimel N, Jouinot A, Huillard O, Boudou-Rouquette P, et al. Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients. Invest New Drugs 2017; 35: 436–41. doi: 10.1007/s10637-017-0464-x. Erratum in: Invest New Drugs 2017; 35: 537. doi: 10.1007/s10637-017-0475-7HeidelbergerVGoldwasserFKramkimelNJouinotAHuillardOBoudou-RouquettePSarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients2017354364110.1007/s10637-017-0464-xErratum in: Invest New Drugs 2017; 35: 537.10.1007/s10637-017-0475-7Open DOISearch in Google Scholar
Jabbour J, Manana B, Zahreddine A, Saade C, Charafeddine M, Bazarbachi A, et al. Sarcopenic obesity derived from PET/CT predicts mortality in lymphoma patients undergoing hematopoietic stem cell transplantation. Curr Res Transl Med 2019; 67: 93–9. doi: 10.1016/j.retram.2018.12.001JabbourJMananaBZahreddineASaadeCCharafeddineMBazarbachiASarcopenic obesity derived from PET/CT predicts mortality in lymphoma patients undergoing hematopoietic stem cell transplantation20196793910.1016/j.retram.2018.12.001Open DOISearch in Google Scholar
Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Writing group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019; 48: 601. doi: 10.1093/ageing/afz046. Erratum for: Age Ageing 2019; 48: 16–31. doi: 10.1093/ageing/afy169Cruz-JentoftAJBahatGBauerJBoirieYBruyèreOCederholmTWriting group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis20194860110.1093/ageing/afz046Erratum for: Age Ageing 2019; 48: 16–31.10.1093/ageing/afy169Open DOISearch in Google Scholar
Mei KL, Batsis JA, Mills JB, Holubar SD. Sarcopenia and sarcopenic obesity: do they predict inferior oncologic outcomes after gastrointestinal cancer surgery? Perioper Med 2016; 5: 30. doi: 10.1186/s13741-016-0052-1MeiKLBatsisJAMillsJBHolubarSDSarcopenia and sarcopenic obesity: do they predict inferior oncologic outcomes after gastrointestinal cancer surgery?201653010.1186/s13741-016-0052-1Open DOISearch in Google Scholar
Prado CM, Heymsfield SB. Lean tissue imaging: a new era for nutritional assessment and intervention. JPEN J Parenter Enteral Nutr 2014; 38: 940–53. doi: 10.1177/0148607114550189. Erratum in: JPEN J Parenter Enteral Nutr 2016; 40: 742. doi: 10.1177/0148607116647919PradoCMHeymsfieldSBLean tissue imaging: a new era for nutritional assessment and intervention2014389405310.1177/0148607114550189Erratum in: JPEN J Parenter Enteral Nutr 2016; 40: 742.10.1177/0148607116647919Open DOISearch in Google Scholar
Donini LM, Busetto L, Bauer JM, Bischoff S, Boirie Y, Cederholm T, et al. Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review. Clin Nutr 2020; 39: 2368–88. doi: 10.1016/j.clnu.2019.11.024DoniniLMBusettoLBauerJMBischoffSBoirieYCederholmTCritical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review20203923688810.1016/j.clnu.2019.11.024Open DOISearch in Google Scholar
Ji T, Li Y, Ma L. Sarcopenic obesity: an emerging public health problem. Aging Dis 2022; 13: 379–88. doi: 10.14336/AD.2021.1006JiTLiYMaLSarcopenic obesity: an emerging public health problem2022133798810.14336/AD.2021.1006Open DOISearch in Google Scholar
Batsis JA, Villareal DT. Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies. Nat Rev Endocrinol 2018; 14: 513–37. doi: 10.1038/s41574-018-0062-9BatsisJAVillarealDTSarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies2018145133710.1038/s41574-018-0062-9Open DOISearch in Google Scholar
Lynch GM, Murphy CH, Castro EM, Roche HM. Inflammation and metabolism: the role of adiposity in sarcopenic obesity. Proc Nutr Soc 2020; 16: 1–13. doi: 10.1017/S0029665120007119LynchGMMurphyCHCastroEMRocheHMInflammation and metabolism: the role of adiposity in sarcopenic obesity20201611310.1017/S0029665120007119Open DOISearch in Google Scholar
Guo A, Li K, Xiao Q. Sarcopenic obesity: myokines as potential diagnostic biomarkers and therapeutic targets? Exp Gerontol 2020; 139: 111022. doi: 10.1016/j.exger.2020.111022GuoALiKXiaoQSarcopenic obesity: myokines as potential diagnostic biomarkers and therapeutic targets?202013911102210.1016/j.exger.2020.111022Open DOISearch in Google Scholar
Murton AJ, Marimuthu K, Mallinson JE, Selby AL, Smith K, Rennie MJ, et al. Obesity appears to be associated with altered muscle protein synthetic and breakdown responses to increased nutrient delivery in older men, but not reduced muscle mass or contractile function. Diabetes 2015; 64: 3160–71. doi: 10.2337/db15-0021MurtonAJMarimuthuKMallinsonJESelbyALSmithKRennieMJObesity appears to be associated with altered muscle protein synthetic and breakdown responses to increased nutrient delivery in older men, but not reduced muscle mass or contractile function20156431607110.2337/db15-0021Open DOISearch in Google Scholar
Abbass T, Dolan RD, Laird BJ, McMillan DC. The relationship between imaging-based body composition analysis and the systemic inflammatory response in patients with cancer: A systematic review. Cancers 2019; 11: 1304. doi: 10.3390/cancers11091304AbbassTDolanRDLairdBJMcMillanDCThe relationship between imaging-based body composition analysis and the systemic inflammatory response in patients with cancer: A systematic review201911130410.3390/cancers11091304Open DOISearch in Google Scholar
Fouladiun M, Körner U, Bosaeus I, Daneryd P, Hyltander A, Lundholm KG. Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care – correlations with food intake, metabolism, exercise capacity, and hormones. Cancer 2005; 103: 2189–98. doi: 10.1002/cncr.21013FouladiunMKörnerUBosaeusIDanerydPHyltanderALundholmKGBody composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care – correlations with food intake, metabolism, exercise capacity, and hormones200510321899810.1002/cncr.21013Open DOISearch in Google Scholar
Baracos VE, Martin L, Korc M, Guttridge DC, Fearon KCH. Cancer-associated cachexia. Nat Rev Dis Primers 2018; 4: 17105. doi: 10.1038/nrdp.2017.105BaracosVEMartinLKorcMGuttridgeDCFearonKCHCancer-associated cachexia201841710510.1038/nrdp.2017.105Open DOISearch in Google Scholar
Baracos VE, Arribas L. Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy. Ann Oncol 2018; 29(Suppl 2): ii1–9. doi: 10.1093/annonc/mdx810BaracosVEArribasLSarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy201829Suppl 2ii1910.1093/annonc/mdx810Open DOISearch in Google Scholar
Murphy RA, Mourtzakis M, Chu QS, Reiman T, Mazurak VC. Skeletal muscle depletion is associated with reduced plasma (n-3) fatty acids in non-small cell lung cancer patients. J Nutr 2010;140: 1602–6. doi: 10.3945/jn.110.123521MurphyRAMourtzakisMChuQSReimanTMazurakVCSkeletal muscle depletion is associated with reduced plasma (n-3) fatty acids in non-small cell lung cancer patients20101401602610.3945/jn.110.123521Open DOISearch in Google Scholar
Martin L, Gioulbasanis I, Senesse P, Baracos VE. Cancer-associated malnutrition and CT-defined sarcopenia and myosteatosis are endemic in over-weight and obese patients. JPEN J Parenter Enteral Nutr 2020; 44: 227–38. doi: 10.1002/jpen.1597MartinLGioulbasanisISenessePBaracosVECancer-associated malnutrition and CT-defined sarcopenia and myosteatosis are endemic in over-weight and obese patients2020442273810.1002/jpen.1597Open DOISearch in Google Scholar
Correa-de-Araujo R, Addison O, Miljkovic I, Goodpaster BH, Bergman BC, Clark RV, et al. Myosteatosis in the context of skeletal muscle function deficit: an interdisciplinary workshop at the National Institute on Aging. Front Physiol 2020; 11: 963. doi: 10.3389/fphys.2020.00963Correa-de-AraujoRAddisonOMiljkovicIGoodpasterBHBergmanBCClarkRVMyosteatosis in the context of skeletal muscle function deficit: an interdisciplinary workshop at the National Institute on Aging20201196310.3389/fphys.2020.00963Open DOISearch in Google Scholar
Gemmink A, Goodpaster BH, Schrauwen P, Hesselink MKC. Intramyocellular lipid droplets and insulin sensitivity, the human perspective. Biochim Biophys Acta Mol Cell Biol Lipids 2017; 1862(10 Pt B): 1242–9. doi: 10.1016/j.bbalip.2017.07.010GemminkAGoodpasterBHSchrauwenPHesselinkMKCIntramyocellular lipid droplets and insulin sensitivity, the human perspective2017186210 Pt B1242910.1016/j.bbalip.2017.07.010Open DOISearch in Google Scholar
Maltais A, Alméras N, Lemieux I, Tremblay A, Bergeron J, Poirier P, et al. Trunk muscle quality assessed by computed tomography: association with adiposity indices and glucose tolerance in men. Metabolism 2018; 85: 205–12. doi: 10.1016/j.metabol.2018.04.003MaltaisAAlmérasNLemieuxITremblayABergeronJPoirierPTrunk muscle quality assessed by computed tomography: association with adiposity indices and glucose tolerance in men2018852051210.1016/j.metabol.2018.04.003Open DOISearch in Google Scholar
Rollins KE, Tewari N, Ackner A, Awwad A, Madhusudan S, Macdonald IA, et al. The impact of sarcopenia and myosteatosis on outcomes of unresecTable pancreatic cancer or distal cholangiocarcinoma. Clin Nutr 2016; 35: 1103–9. doi: 10.1016/j.clnu.2015.08.005RollinsKETewariNAcknerAAwwadAMadhusudanSMacdonaldIAThe impact of sarcopenia and myosteatosis on outcomes of unresecTable pancreatic cancer or distal cholangiocarcinoma2016351103910.1016/j.clnu.2015.08.005Open DOISearch in Google Scholar
Knapp ML, al-Sheibani S, Riches PG, Hanham IW, Phillips RH. Hormonal factors associated with weight loss in patients with advanced breast cancer. Ann Clin Biochem 1991; 28 (Pt 5): 480–6. doi: 10.1177/000456329102800510KnappMLal-SheibaniSRichesPGHanhamIWPhillipsRHHormonal factors associated with weight loss in patients with advanced breast cancer199128Pt 5480610.1177/000456329102800510Open DOISearch in Google Scholar
Crown AL, Cottle K, Lightman SL, Falk S, Mohamed-Ali V, Armstrong L, et al. What is the role of the insulin-like growth factor system in the pathophysiology of cancer cachexia, and how is it regulated? Clin Endocrinol 2002; 56: 723–33. doi: 10.1046/j.1365-2265.2002.01540.xCrownALCottleKLightmanSLFalkSMohamed-AliVArmstrongLWhat is the role of the insulin-like growth factor system in the pathophysiology of cancer cachexia, and how is it regulated?2002567233310.1046/j.1365-2265.2002.01540.xOpen DOISearch in Google Scholar
Yoshikawa T, Noguchi Y, Doi C, Makino T, Nomura K. Insulin resistance in patients with cancer: relationships with tumor site, tumor stage, body-weight loss, acute-phase response, and energy expenditure. Nutrition 2001; 17: 590–3. doi: 10.1016/s0899-9007(01)00561-5YoshikawaTNoguchiYDoiCMakinoTNomuraKInsulin resistance in patients with cancer: relationships with tumor site, tumor stage, body-weight loss, acute-phase response, and energy expenditure200117590310.1016/s0899-9007(01)00561-5Open DOISearch in Google Scholar
Hoffmann C, Weigert C. Skeletal muscle as an endocrine organ: the role of myokines in exercise adaptations. Cold Spring Harb Perspect Med 2017; 7: a029793. doi: 10.1101/cshperspect.a029793HoffmannCWeigertCSkeletal muscle as an endocrine organ: the role of myokines in exercise adaptations20177a02979310.1101/cshperspect.a029793Open DOISearch in Google Scholar
Jurdana M. Physical activity and cancer risk. Actual knowledge and possible biological mechanisms. Radiol Oncol 2021; 55: 7–17. doi: 10.2478/raon-2020-0063JurdanaMPhysical activity and cancer risk. Actual knowledge and possible biological mechanisms20215571710.2478/raon-2020-0063Open DOISearch in Google Scholar
Rivas DA, McDonald DJ, Rice NP, Haran PH, Dolnikowski GG, Fielding RA. Diminished anabolic signaling response to insulin induced by intramuscular lipid accumulation is associated with inflammation in aging but not obesity. Am J Physiol Regul Integr Comp Physiol 2016; 310: R561–9. doi: 10.1152/ajpregu.00198.2015RivasDAMcDonaldDJRiceNPHaranPHDolnikowskiGGFieldingRADiminished anabolic signaling response to insulin induced by intramuscular lipid accumulation is associated with inflammation in aging but not obesity2016310R561910.1152/ajpregu.00198.2015Open DOISearch in Google Scholar
Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002; 8: 1288–95. doi: 10.1038/nm788YamauchiTKamonJMinokoshiYItoYWakiHUchidaSAdiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase2002812889510.1038/nm788Open DOISearch in Google Scholar
Hong SH, Choi KM. Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences. Int J Mol Sci 2020; 21: 494. doi: 10.3390/ijms21020494HongSHChoiKMSarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences20202149410.3390/ijms21020494Open DOISearch in Google Scholar
Hamrick MW. Role of the cytokine-like hormone leptin in muscle-bone crosstalk with aging. J Bone Metab 2017; 24: 1–8. doi: 10.11005/jbm.2017.24.1.1HamrickMWRole of the cytokine-like hormone leptin in muscle-bone crosstalk with aging2017241810.11005/jbm.2017.24.1.1Open DOISearch in Google Scholar
Kurdiova T, Balaz M, Vician M, Maderova D, Vlcek M, Valkovic L, et al. Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies. J Physiol 2014; 592: 1091–107. doi: 10.1113/jphysiol.2013.264655KurdiovaTBalazMVicianMMaderovaDVlcekMValkovicLEffects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies2014592109110710.1113/jphysiol.2013.264655Open DOISearch in Google Scholar
Johns N, Greig C, Fearon KC. Is tissue cross-talk important in cancer cachexia? Crit Rev Oncog 2012; 17: 263–76. doi: 10.1615/critrevoncog.v17.i3.40JohnsNGreigCFearonKCIs tissue cross-talk important in cancer cachexia?2012172637610.1615/critrevoncog.v17.i3.40Open DOISearch in Google Scholar
Argilés JM, Busquets S, Stemmler B, López-Soriano FJ. Cancer cachexia: understanding the molecular basis. Nat Rev Cancer 2014; 14: 754–62. doi: 10.1038/nrc3829ArgilésJMBusquetsSStemmlerBLópez-SorianoFJCancer cachexia: understanding the molecular basis2014147546210.1038/nrc3829Open DOISearch in Google Scholar
Prado CM, Baracos VE, McCargar LJ, Reiman T, Mourtzakis M, Tonkin K, et al. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res 2009; 15: 2920–6. doi: 10.1158/1078-0432.CCR-08-2242PradoCMBaracosVEMcCargarLJReimanTMourtzakisMTonkinKSarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment2009152920610.1158/1078-0432.CCR-08-2242Open DOISearch in Google Scholar
Petrelli F, Cortellini A, Indini A, Tomasello G, Ghidini M, Nigro O, et al. Association of obesity with survival outcomes in patients with cancer: a systematic review and meta-analysis. JAMA Netw Open 2021; 4: e213520 doi: 10.1001/jamanetworkopen.2021.3520PetrelliFCortelliniAIndiniATomaselloGGhidiniMNigroOAssociation of obesity with survival outcomes in patients with cancer: a systematic review and meta-analysis20214e21352010.1001/jamanetworkopen.2021.3520Open DOISearch in Google Scholar
Gallo M, Adinolfi V, Barucca V, Prinzi N, Renzelli V, Barrea L, et al. Expected and paradoxical effects of obesity on cancer treatment response. Rev Endocr Metab Disord 2021; 22: 681–702. doi: 10.1007/s11154-020-09597-yGalloMAdinolfiVBaruccaVPrinziNRenzelliVBarreaLExpected and paradoxical effects of obesity on cancer treatment response20212268170210.1007/s11154-020-09597-yOpen DOISearch in Google Scholar
Prado CM, Purcell SA, Laviano A. Nutrition interventions to treat low muscle mass in cancer. J Cachexia Sarcopenia Muscle 2020; 11: 366–80. doi: 10.1002/jcsm.12525PradoCMPurcellSALavianoANutrition interventions to treat low muscle mass in cancer2020113668010.1002/jcsm.12525Open DOISearch in Google Scholar
Argilés JM, Busquets S, López-Soriano FJ, Costelli P, Penna F. Are there any benefits of exercise training in cancer cachexia? J Cachexia Sarcopenia Muscle 2012; 3: 73–6. doi: 10.1007/s13539-012-0067-5ArgilésJMBusquetsSLópez-SorianoFJCostelliPPennaFAre there any benefits of exercise training in cancer cachexia?2012373610.1007/s13539-012-0067-5Open DOISearch in Google Scholar
Stene GB, Helbostad JL, Balstad TR, Riphagen II, Kaasa S, Oldervoll LM. Effect of physical exercise on muscle mass and strength in cancer patients during treatment--a systematic review. Crit Rev Oncol Hematol 2013; 88: 573–93. doi: 10.1016/j.critrevonc.2013.07.001SteneGBHelbostadJLBalstadTRRiphagenIIKaasaSOldervollLMEffect of physical exercise on muscle mass and strength in cancer patients during treatment--a systematic review2013885739310.1016/j.critrevonc.2013.07.001Open DOISearch in Google Scholar
Galvão DA, Newton RU. Review of exercise intervention studies in cancer patients. J Clin Oncol 2005; 23: 899–909. doi: 10.1200/JCO.2005.06.085GalvãoDANewtonRUReview of exercise intervention studies in cancer patients20052389990910.1200/JCO.2005.06.085Open DOISearch in Google Scholar
Poggiogalle E, Parrinello E, Barazzoni R, Busetto L, Donini LM. Therapeutic strategies for sarcopenic obesity: a systematic review. Curr Opin Clin Nutr Metab Care 2021; 24: 33–41. doi: 10.1097/MCO.0000000000000714PoggiogalleEParrinelloEBarazzoniRBusettoLDoniniLMTherapeutic strategies for sarcopenic obesity: a systematic review202124334110.1097/MCO.0000000000000714Open DOISearch in Google Scholar
Verschueren SM, Bogaerts A, Delecluse C, Claessens AL, Haentjens P, Vanderschueren D, et al. The effects of whole-body vibration training and vitamin D supplementation on muscle strength, muscle mass, and bone density in institutionalized elderly women: a 6-month randomized, controlled trial. J Bone Miner Res 2011; 26: 42–9. doi: 10.1002/jbmrVerschuerenSMBogaertsADelecluseCClaessensALHaentjensPVanderschuerenDThe effects of whole-body vibration training and vitamin D supplementation on muscle strength, muscle mass, and bone density in institutionalized elderly women: a 6-month randomized, controlled trial20112642910.1002/jbmrOpen DOISearch in Google Scholar
Gyergyek, A, Rotovnik Kozjek N, Klen, J. Monitoring the effect of perioperative nutritional care on body composition and functional status in patients with carcinoma of gastrointestinal and hepatobiliary system and pancreas. Radiol Oncol 2023; 57: 371–9. doi: 10.2478/raon-2023-0028GyergyekARotovnik KozjekNKlenJMonitoring the effect of perioperative nutritional care on body composition and functional status in patients with carcinoma of gastrointestinal and hepatobiliary system and pancreas202357371910.2478/raon-2023-0028Open DOISearch in Google Scholar